Roche shares hit by trial flops, fears over biosimilar defence

ZURICH, Sept 11 (Reuters) – Roche shares fell inearly trading on Monday after trial failures added to the Swissdrugmaker’s challenge of replacing patent-expired medicines withlucrative new drugs.
The post Roche shares hit by trial flops, fears over biosimilar defence appeared first on RocketNews | Top News Stories From Around the Globe.